What is Hyloris Pharmaceuticals S.A.?
Hyloris Pharmaceuticals SA operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Hyloris Pharmaceuticals SA operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific. The company offers Maxigesic IV for the treatment of post-operative pain; Podofilox gel, a topical antimycotic drug for external genital and perianal warts; Sotalol IV, an intravenous formulation of sotalol for the treatment of atrial fibrillation, and life-threatening ventricular arrhythmias; and Valacyclovir oral suspension for the treatment of herpes virus infections. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 152.20M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.